These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Urinary N-acetyl-beta-D-glucosaminidase assay in renal transplant recipients. Wellwood JM, Davies D, Leighton M, Thompson AE. Transplantation; 1978 Dec 15; 26(6):396-400. PubMed ID: 366824 [Abstract] [Full Text] [Related]
69. Pathophysiology of increased urinary N-acetyl-beta-D-glucosaminidase activity in human hypertension: effect of cilazapril therapy. Simon G, Peterson S. Clin Exp Hypertens A; 1988 Dec 15; 10(5):767-77. PubMed ID: 2972422 [Abstract] [Full Text] [Related]
70. Renal disease in rheumatoid arthritis. Dieppe PA, Doyle DV, Burry HC, Tucker SM. Br Med J; 1976 Mar 13; 1(6010):611-2. PubMed ID: 1252848 [Abstract] [Full Text] [Related]
72. Clinical significance of urinary enzymes in diabetic nephropathy. Morita E, Kaizu K, Uriu K, Hashimoto O, Komine N, Eto S. J Diabet Complications; 1991 Mar 13; 5(2-3):158-9. PubMed ID: 1685160 [Abstract] [Full Text] [Related]
73. Urinary N-acetyl-beta-D-glucosaminidase as an indicator of tubular damage in multiple myeloma. Coward RA, DeLamore IW, Mallick NP, Robinson LE. Clin Chim Acta; 1984 Apr 27; 138(3):293-8. PubMed ID: 6426824 [Abstract] [Full Text] [Related]
74. [Alterations in urinary N-Acetyl-beta-D-glucosaminidase (NAG), beta 2-microglobulin (BMG) under acute exposure to simulated 6,000 m altitude]. Sato T, Yamada Y, Hatano Y, Nishikawa E, Fukatsu H, Segawa A, Matsui N. Hinyokika Kiyo; 1985 Apr 27; 31(4):607-14. PubMed ID: 3898773 [Abstract] [Full Text] [Related]
75. Urinary N-acetyl-beta-D-glucosaminidase as a marker of renal injury in adjuvant arthritis. Franch MA, Moreno JJ, Castell M, Queralt J. Res Exp Med (Berl); 1990 Apr 27; 190(3):213-8. PubMed ID: 2367746 [Abstract] [Full Text] [Related]